In addition, Src activity is also regulated by phosphorylation of the C-terminal negative regulatory Tyr530 site, as point mutations or loss of C-terminal residues results in constitutively active Src, which is often seen in colon cancers patients [12, 13]. Here, SRC is linked to malignant colon neoplasm.